These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24928990)

  • 1. Real-time detection of CTL function reveals distinct patterns of caspase activation mediated by Fas versus granzyme B.
    Li J; Figueira SK; Vrazo AC; Binkowski BF; Butler BL; Tabata Y; Filipovich A; Jordan MB; Risma KA
    J Immunol; 2014 Jul; 193(2):519-28. PubMed ID: 24928990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granzyme C supports efficient CTL-mediated killing late in primary alloimmune responses.
    Getachew Y; Stout-Delgado H; Miller BC; Thiele DL
    J Immunol; 2008 Dec; 181(11):7810-7. PubMed ID: 19017970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid.
    Barry M; Heibein JA; Pinkoski MJ; Lee SF; Moyer RW; Green DR; Bleackley RC
    Mol Cell Biol; 2000 Jun; 20(11):3781-94. PubMed ID: 10805722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
    Anel A; Gamen S; Alava MA; Schmitt-Verhulst AM; Piñeiro A; Naval J
    J Immunol; 1997 Mar; 158(5):1999-2006. PubMed ID: 9036942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell death induction by CTL: perforin/granzyme B system dominantly acts for cell death induction in human hepatocellular carcinoma cells.
    Hayashida M; Kawano H; Nakano T; Shiraki K; Suzuki A
    Proc Soc Exp Biol Med; 2000 Nov; 225(2):143-50. PubMed ID: 11044257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms responsible for granzyme B-independent cytotoxicity.
    Shresta S; Russell JH; Ley TJ
    Blood; 1997 Jun; 89(11):4085-91. PubMed ID: 9166849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression.
    Delgado M; Ganea D
    J Immunol; 2000 Jul; 165(1):114-23. PubMed ID: 10861043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granzyme B: a natural born killer.
    Lord SJ; Rajotte RV; Korbutt GS; Bleackley RC
    Immunol Rev; 2003 Jun; 193():31-8. PubMed ID: 12752668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulysin delivered by cytotoxic cells damages endoplasmic reticulum and activates caspase-7 in target cells.
    Saini RV; Wilson C; Finn MW; Wang T; Krensky AM; Clayberger C
    J Immunol; 2011 Mar; 186(6):3497-504. PubMed ID: 21296981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T cells specifically induce Fas on target cells, thereby facilitating exocytosis-independent induction of apoptosis.
    Simon MM; Waring P; Lobigs M; Nil A; Tran T; Hla RT; Chin S; Müllbacher A
    J Immunol; 2000 Oct; 165(7):3663-72. PubMed ID: 11034370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live cell evaluation of granzyme delivery and death receptor signaling in tumor cells targeted by human natural killer cells.
    Vrazo AC; Hontz AE; Figueira SK; Butler BL; Ferrell JM; Binkowski BF; Li J; Risma KA
    Blood; 2015 Aug; 126(8):e1-e10. PubMed ID: 26124495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 potentiation of tumor cell susceptibility to CTL involves Fas and mitochondrial pathways.
    Thiery J; Abouzahr S; Dorothee G; Jalil A; Richon C; Vergnon I; Mami-Chouaib F; Chouaib S
    J Immunol; 2005 Jan; 174(2):871-8. PubMed ID: 15634909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filamin (280-kDa actin-binding protein) is a caspase substrate and is also cleaved directly by the cytotoxic T lymphocyte protease granzyme B during apoptosis.
    Browne KA; Johnstone RW; Jans DA; Trapani JA
    J Biol Chem; 2000 Dec; 275(50):39262-6. PubMed ID: 11050075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
    Yanai F; Ishii E; Kojima K; Hasegawa A; Azuma T; Hirose S; Suga N; Mitsudome A; Zaitsu M; Ishida Y; Shirakata Y; Sayama K; Hashimoto K; Yasukawa M
    J Immunol; 2003 Feb; 170(4):2205-13. PubMed ID: 12574394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
    Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
    J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas- and perforin-independent mechanism of cytotoxic T lymphocyte.
    Kajino K; Kajino Y; Greene MI
    Immunol Res; 1998; 17(1-2):89-93. PubMed ID: 9479571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
    Yang S; Haluska FG
    J Immunol; 2004 Apr; 172(7):4599-608. PubMed ID: 15034078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granzyme B activity in target cells detects attack by cytotoxic lymphocytes.
    Packard BZ; Telford WG; Komoriya A; Henkart PA
    J Immunol; 2007 Sep; 179(6):3812-20. PubMed ID: 17785818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time.
    Jenkins MR; Rudd-Schmidt JA; Lopez JA; Ramsbottom KM; Mannering SI; Andrews DM; Voskoboinik I; Trapani JA
    J Exp Med; 2015 Mar; 212(3):307-17. PubMed ID: 25732304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms.
    Smith DJ; McGuire MJ; Tocci MJ; Thiele DL
    J Immunol; 1997 Jan; 158(1):163-70. PubMed ID: 8977187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.